Why the study?
Does achieving HbA1c < 7.0 at 2 years after percutaneous coronary intervention reduce MACCE in patients with Type 2 Diabetes Mellitus?
Does achieving HbA1c < 7.0 at 2 years after percutaneous coronary intervention reduce MACCE in patients with Type 2 Diabetes Mellitus?
Maintaining good glycemic control (HbA1c < 7.0) 2 years post-PCI in diabetic patients is associated with reduced long-term MACCE and repeat revascularization.
Answers are grounded in this paper and cite their sources.
Should not yet change post-PCI glycemic targets; leaves open whether HbA1c <7.0 reduces MACCE.
HbA1c<7.0 measured 2 years after percutaneous coronary intervention was associated with a reduced rate of MACCE. Our data suggest that high HbA1c levels 2 years after percutaneous coronary intervention may identify a population at increased risk of adverse events, especially repeat revascularization.
No takes yet. Share an insight, caveat, or question.
Hwang et al. (2017) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: